Reduced susceptibility to induced seizures in the Neuroligin-3R451C mouse model of autism

Neuroscience Letters

Volumn 589, Issue , 2015, Pages 57-61

  Hill Yardin, Elisa L ^a   Argyropoulos, Andrew ^a   Hosie, Suzanne ^a   Rind, Gil ^a   Anderson, Paul ^a   Hannan, Anthony J ^a,b   O'Brien, Terence J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

Autism; Epilepsy; Mice; Pentylenetetrazole; Seizures; Tonic clonic

Indexed keywords

NEUROLIGIN; NEUROLIGIN 3; PENTETRAZOLE; UNCLASSIFIED DRUG; CELL ADHESION MOLECULES, NEURONAL; NEUROLIGIN 1; PENTYLENETETRAZOLE;

ABSENCE; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTISM; CLONIC SEIZURE; DISEASE DURATION; HIPPOCAMPUS; MALE; MORBIDITY; MOUSE; NONHUMAN; PHYSICAL PARAMETERS; POINT MUTATION; PRIORITY JOURNAL; SEIZURE; SEIZURE SUSCEPTIBILITY; SOMATOSENSORY CORTEX; SPIKE AND WAVE DISCHARGE; TONIC CLONIC SEIZURE; ANIMALS; CHILD DEVELOPMENT DISORDERS, PERVASIVE; COMPLICATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GENETIC PREDISPOSITION TO DISEASE; GENETICS; MICE; MUTATION; PHYSIOPATHOLOGY; SEIZURES;

ANIMALS; CELL ADHESION MOLECULES, NEURONAL; CHILD DEVELOPMENT DISORDERS, PERVASIVE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENETIC PREDISPOSITION TO DISEASE; MALE; MICE; MUTATION; PENTYLENETETRAZOLE; SEIZURES;

EID: 84922670666     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2015.01.024     Document Type: Article

References (37)

1. Allen A.S., Berkovic S.F., Cossette P., Delanty N., Dlugos D., Eichler E.E., Epstein M.P., Glauser T., Goldstein D.B., Han Y., Heinzen E.L., Hitomi Y., Howell K.B., Johnson M.R., Kuzniecky R., Lowenstein D.H., Lu Y.F., Madou M.R., Marson A.G., Mefford H.C., Esmaeeli Nieh S., O'Brien T.J., Ottman R., Petrovski S., Poduri A., Ruzzo E.K., Scheffer I.E., Sherr E.H., Yuskaitis C.J., Abou-Khalil B., Alldredge B.K., Bautista J.F., Boro A., Cascino G.D., Consalvo D., Crumrine P., Devinsky O., Fiol M., Fountain N.B., French J., Friedman D., Geller E.B., Glynn S., Haut S.R., Hayward J., Helmers S.L., Joshi S., Kanner A., Kirsch H.E., Knowlton R.C., Kossoff E.H., Kuperman R., McGuire S.M., Motika P.V., Novotny E.J., Paolicchi J.M., Parent J.M., Park K., Shellhaas R.A., Shih J.J., Singh R., Sirven J., Smith M.C., Sullivan J., Lin Thio L., Venkat A., Vining E.P., Von Allmen G.K., Weisenberg J.L., Widdess-Walsh P., Winawer M.R. De novo mutations in epileptic encephalopathies. Nature 2013, 501:217-221.
2. Ben-Ari Y., Khalilov I., Kahle K.T., Cherubini E. The GABA excitatory/inhibitory shift in brain maturation and neurological disorders. Neurosci.: A Rev. J. Bringing Neurobiol. Neurol. Psychiatry 2012, 18:467-486.
3. Bernard C., Cossart R., Hirsch J.C., Esclapez M., Ben-Ari Y. What is GABAergic inhibition? How is it modified in epilepsy?. Epilepsia 2000, 41(Suppl 6):S90-S95.
4. Betancur C. Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Res. 2011, 1380:42-77.
5. Betancur C., Sakurai T., Buxbaum J.D. The emerging role of synaptic cell-adhesion pathways in the pathogenesis of autism spectrum disorders. Trends Neurosci. 2009, 32:402-412.
6. Chez M.G., Buchanan T., Aimonovitch M., Mrazek S., Krasne V., Langburt W., Memon S. Frequency of EEG abnormalities in age-matched siblings of autistic children with abnormal sleep EEG patterns. Epilepsy Behav. 2004, 5:159-162.
7. Chez M.G., Chang M., Krasne V., Coughlan C., Kominsky M., Schwartz A. Frequency of epileptiform EEG abnormalities in a sequential screening of autistic patients with no known clinical epilepsy from 1996 to 2005. Epilepsy Behav. 2006, 8:267-271.
8. Chipaux M., Vercueil L., Kaminska A., Mahon S., Charpier S. Persistence of cortical sensory processing during absence seizures in human and an animal model: evidence from EEG and intracellular recordings. PloS One 2013, 8:e58180.
9. Chiu C., Reid C.A., Tan H.O., Davies P.J., Single F.N., Koukoulas I., Berkovic S.F., Tan S.S., Sprengel R., Jones M.V., Petrou S. Developmental impact of a familial GABAA receptor epilepsy mutation. Ann. Neurol. 2008, 64:284-293.
10. Deckers C.L., Czuczwar S.J., Hekster Y.A., Keyser A., Kubova H., Meinardi H., Patsalos P.N., Renier W.O., Van Rijn C.M. Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed. Epilepsia 2000, 41:1364-1374.
11. Delahanty R.J., Kang J.Q., Brune C.W., Kistner E.O., Courchesne E., Cox N.J., Cook E.H., Macdonald R.L., Sutcliffe J.S. Maternal transmission of a rare GABRB3 signal peptide variant is associated with autism. Mol. Psychiatry 2011, 16:86-96.
12. R451C mutation differentially alters hippocampal and cortical synaptic function. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:13764-13769.
13. Foldy C., Malenka R.C., Sudhof T.C. Autism-associated Neuroligin-3 mutations commonly disrupt tonic endocannabinoid signaling. Neuron 2013, 78:498-509.
14. Gage G.J., Stoetzner C.R., Richner T., Brodnick S.K., Williams J.C., Kipke D.R. Surgical implantation of chronic neural electrodes for recording single unit activity and electrocorticographic signals. J. Vis. Exp. 2012, 60(February 24). pii: 3565. 10.3791/3565.
15. Gutierrez G.C., Smalley S.L., Tanguay P.E. Autism in tuberous sclerosis complex. J. Autism Dev. Disord. 1998, 28:97-103.
16. Hakami T., Jones N.C., Tolmacheva E.A., Gaudias J., Chaumont J., Salzberg M., O'Brien T.J., Pinault D. NMDA receptor hypofunction leads to generalized and persistent aberrant gamma oscillations independent of hyperlocomotion and the state of consciousness. PLoS One 2009, 4:e6755.
17. Han S., Tai C., Westenbroek R.E., Yu F.H., Cheah C.S., Potter G.B., Rubenstein J.L., Scheuer T., de la Iglesia H.O., Catterall W.A. Autistic-like behaviour in Scn1a+/- mice and rescue by enhanced GABA-mediated neurotransmission. Nature 2012, 489:385-390.
18. Harai T., Inoue R., Fujita Y., Tanaka A., Horio M., Hashimoto K., Hongou K., Miyawaki T., Mori H. Decreased susceptibility to seizures induced by pentylenetetrazole in serine racemase knockout mice. Epilepsy Res. 2012, 102:180-187.
19. Huang R.Q., Bell-Horner C.L., Dibas M.I., Covey D.F., Drewe J.A., Dillon G.H. Pentylenetetrazole-induced inhibition of recombinant gamma-aminobutyric acid type A (GABA(A)) receptors: mechanism and site of action. J. Pharmacol. Exp. Ther. 2001, 298:986-995.
20. Jamain S., Quach H., Betancur C., Rastam M., Colineaux C., Gillberg I.C., Soderstrom H., Giros B., Leboyer M., Gillberg C., Bourgeron T. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat. Genet. 2003, 34:27-29.
21. McLean K.J., O'Brien T.J., Cook M.J., Vajda F.J. The influence of gender on the aggravation of absence seizures by carbamazepine in the low-dose pentylenetetrazol rat model. Seizure 2004, 13:208-216.
22. Mizoguchi H., Nakade J., Tachibana M., Ibi D., Someya E., Koike H., Kamei H., Nabeshima T., Itohara S., Takuma K., Sawada M., Sato J., Yamada K. Matrix metalloproteinase-9 contributes to kindled seizure development in pentylenetetrazole-treated mice by converting pro-BDNF to mature BDNF in the hippocampus. J. Neurosci.: Off. J. Soc. Neurosci. 2011, 31:12963-12971.
23. Parmeggiani A., Barcia G., Posar A., Raimondi E., Santucci M., Scaduto M.C. Epilepsy and EEG paroxysmal abnormalities in autism spectrum disorders. Brain Dev. 2010, 32:783-789.
24. Penagarikano O., Abrahams B.S., Herman E.I., Winden K.D., Gdalyahu A., Dong H., Sonnenblick L.I., Gruver R., Almajano J., Bragin A., Golshani P., Trachtenberg J.T., Peles E., Geschwind D.H. Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits. Cell 2011, 147:235-246.
25. Pinault D. N-methyl-d-aspartate receptor antagonists ketamine and MK-801 induce wake-related aberrant gamma oscillations in the rat neocortex. Biol. Psychiatry 2008, 63:730-735.
26. R451C knock-in mice: an animal model of Autism. Front. Cell. Neurosci. 2013, 7:85.
27. Radyushkin K., Hammerschmidt K., Boretius S., Varoqueaux F., El-Kordi A., Ronnenberg A., Winter D., Frahm J., Fischer J., Brose N., Ehrenreich H. Neuroligin-3-deficient mice: model of a monogenic heritable form of autism with an olfactory deficit. Genes Brain Behav. 2009, 8:416-425.
28. Rothwell P.E., Fuccillo M.V., Maxeiner S., Hayton S.J., Gokce O., Lim B.K., Fowler S.C., Malenka R.C., Sudhof T.C. Autism-associated Neuroligin-3 mutations commonly impair striatal circuits to boost repetitive behaviors. Cell 2014, 158:198-212.
29. Rubenstein J.L., Merzenich M.M. Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav. 2003, 2:2-255.
30. Small J.G. EEG and neurophysiological studies of early infantile autism. Biol. Psychiatry 1975, 10:385-397.
31. Snead O.C. Pharmacological models of generalized absence seizures in rodents. J. Neural. Transm. Suppl. 1992, 35:7-19.
32. Tabuchi K., Blundell J., Etherton M.R., Hammer R.E., Liu X., Powell C.M., Sudhof T.C. A Neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 2007, 318:71-76.
33. Tai C., Abe Y., Westenbroek R.E., Scheuer T., Catterall W.A. Impaired excitability of somatostatin- and parvalbumin-expressing cortical interneurons in a mouse model of Dravet syndrome. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:E3139-3148.
34. Tan H.O., Reid C.A., Single F.N., Davies P.J., Chiu C., Murphy S., Clarke A.L., Dibbens L., Krestel H., Mulley J.C., Jones M.V., Seeburg P.H., Sakmann B., Berkovic S.F., Sprengel R., Petrou S. Reduced cortical inhibition in a mouse model of familial childhood absence epilepsy. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:17536-17541.
35. Uhlhaas P.J., Singer W. Neural synchrony in brain disorders: relevance for cognitive dysfunctions and pathophysiology. Neuron 2006, 52:155-168.
36. Yu F.H., Mantegazza M., Westenbroek R.E., Robbins C.A., Kalume F., Burton K.A., Spain W.J., McKnight G.S., Scheuer T., Catterall W.A. Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat. Neurosci. 2006, 9:1142-1149.
37. Zhang Y., Vilaythong A.P., Yoshor D., Noebels J.L. Elevated thalamic low-voltage-activated currents precede the onset of absence epilepsy in the SNAP25-deficient mouse mutant coloboma. J. Neurosci.: Off. J. Soc. Neurosci. 2004, 24:5239-5248.